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INTRODUCTION
Radiation injuries occurring after a single high-dose irradi-
ation include apoptosis as well as radiation necrosis and ap-
proximately 4% of patients who have received a single high-
dose irradiation suffer from radiation necrosis (1). It has been
assumed that a compromise in cerebral microcirculation due
to vascular endothelial cell injury may play a role in radiation
necrosis (2, 3), however, precise mechanisms for radiation
necrosis are not clearly known. Apoptosis or the programmed
cell death means the natural death of cells, which can be found
as a physiological phenomenon in many growing tissues (4).
It was reported that even the cells of healthy tissues may un-
dergo apoptosis when they are exposed to DNA-destructive
factors, such as radiation, anticancer medicine, and cytotox-
ins (5).
Cytokine is one of the important regulatory proteins con-
trolling the growth and differentiation of normal cerebral
cells and cancer cells exposed to radiation (6-8). Tumor necro-
sis factor- (TNF- ), typical of cytokine, serves as an inter-
mediator of the immune system, protecting the host from
the attacks of various infections and cancer cells, and induces
the death of cancer cells by causing apoptosis (9). Recent stud-
ies have reported that radiation increases the expression of
specific proteins including TNF- (2, 10). Transforming
growth factor- (TGF- ), which is produced mainly from
astrocytes and macrophages, is a polypeptide with various
biological actions in the human body and the expression of
TGF- is also increased after irradiation (3). If we can clarify
the roles of cytokine in relation to radiation injury in normal
cerebral cells after a single high-dose irradiation, we can study
the methods of restricting or accelerating the expression of
the cytokines. And those methods are believed to serve as an
important tool to prevent complications after radiotherapy.
This study was designed to clarify the mechanisms of radia-
tion necrosis and apoptosis taking place after a single high-
dose irradiation, by using the animal model to identify whe-
ther TNF- and TGF- 1 are expressed and from what they
are originated.
MATERIALS AND METHODS
Sixty Sprague-Dawley rats weighing 350-400 g were used
irrespective of their sex. To avoid empty stomach and dehy-
dration, the rats were given water and food ad libitum till the
experiment was conducted.
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Expression of TNF- and TGF- 1 in the Rat Brain After a Single
High-Dose Irradiation
Cytokines and growth factors are important regulatory proteins controlling the
growth and differentiation of normal and malignant glial cells. In this study, we
investigated the expression and origin of tumor necrosis factor- (TNF- ) and
transforming growth factor- 1 (TGF- 1) in the subacute brain injury after a sin-
gle high-dose irradiation using 60 Sprague-Dawley rats. The right cerebral hemi-
spheres of rats were exposed to a single 10 Gy dose of gamma rays using Ir-
192. The radiation effect was assessed at 1 week, 2 weeks, 4 weeks, 6 weeks,
and 8 weeks after irradiation, and the results were compared with those in sham
operation group. Histological changes characteristic of radiation injury were cor-
related with the duration after the single dose irradiation. The loss of cortical thick-
ness also increased with the lapse of time after irradiation. The TNF- expres-
sion in the irradiated cerebral hemispheres was significantly increased compared
with that in the sham operation group. TGF- 1 expression was also increased
in the irradiated hemispheres. Immunohistochemical study revealed that TGF- 1
was expressed predominantly by infiltrating macrophages and astrocytes around
the necrotic areas. These findings indicate that TNF- and TGF- 1 may play
prominent roles in the radiation injuries after a single high-dose irradiation. 
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Single high-dose irradiation and forebrain extirpation
One percent ketamine (50 mg/kg), known to have no radio-
protective effect (11), was injected to the rat intraperitoneally
and then the head was fixed to a head holder (SN-8N Semi-
Chronic Head Holder, Narishige Co., Tokyo, Japan) in a ven-
tral decubitus position. A longitudinal incision was made on
the scalp along the median line. Under an operative micro-
scopy, a hole of an 8-mm diameter was made on the right
parietal area using a small drill to expose the dura mater.
Because it was technically impossible to conduct intraopera-
tive irradiation using electron beams on a tiny rat brain, iridi-
um-192 (GammaMed 12i, MDS Nordion, Canada), which
has the same characteristics as the electron beam and is com-
monly used for high dose rate brachytherapy, was used as a
source of radiation. A shield was made of Lipowitz metal
(Cerrobend
�, MED-TEC, Orange, IA, U.S.A.), and then a
hole of 0.6 cm was made at an appropriate place in the mid-
dle to ensure that the iridium source was located 0.5 cm above
the hole. The source was kept away appropriately to ensure
that the impact of diffused beams on the irradiation site could
be minimized and a portion of 1 cm diameter on the surface
of the rat brain could be exposed to radiation, and that 10 Gy
could be irradiated by a single irradiation on the brain sur-
face 2 cm away from the source (Fig. 1). The 10 Gy dose was
selected because it is known as the lowest dose to have a radi-
ation effect during intraoperative irradiation (12). After irra-
diation, the scalp was sutured in an aseptic condition. Sixty
rats were divided into 6 groups (10 in each group), and their
forebrains were extirpated at 1 week (group A), 2 weeks (group
B), 4 weeks (group C), 6 weeks (group D), and 8 weeks (group
E) after irradiation. Ten non-irradiated rats also underwent
forebrain extirpation at 1 week as a sham operation group.
Histopathological examination
Extirpated brains were fixed in 10% buffered formalin for
6 hr to maintain their antigenicity. Then a coronal section
slice of a 5-mm anteroposterior diameter was made centering
around the irradiated portion. Non-irradiated left cerebral
hemispheres were used as the control group. According to
the usual tissue processing procedure, tissues were passed
through ethanol for dehydration and embedded in paraffin.
Then, a thin section of a 5- m thickness was made and H-
E stained. The cortical thicknesses of irradiated right cere-
bral hemispheres and non-irradiated left hemispheres were
measured to compare the cortical injury. That is, the loss of
irradiated cerebral cortex at various time points was compared,
and the morphological changes with the lapse of time after
irradiation were observed using an optic microscope.
Quantitative analysis of TNF- and TGF- 1 using
enzyme-linked immunosorbent assay (ELISA)
Using the quantitative sandwich ELISA method with an
ELISA kit (Quantikine
�, R&D Systems, Minneapolis, MN),
we quantified the expressions of TNF- and TGF- in the
irradiated right hemispheres and the non-irradiated left hemi-
spheres. As a control group, the brains of the non-irradiated
sham operation group were also used. To extract the protein,
the paraffin-embedded tissues were sectioned in a 10- m
thickness, and then processed in 100% xylene for 5-10 min
at room temperature for deparaffinization. Then they were
centrifuged at 13,000 rpm for 3 min twice, and left in 95%
acetone at room temperature for 5 min. Again, they were cen-
trifuged at 13,000 rpm for 3 min twice and washed in dis-
tilled water for 10 min. With 100  L of protein lysis buffer
put into each tube, they were left at 4℃ for 1 hr, and then
centrifuged at 1,000 rpm for 30 min. Then, the upper layer
was separated for the quantitation of protein according to
the Bradford method (13). The specimen was diluted with a
coating buffer to make 2  g/mL, and then 100  L/well was
put into a 96-well plate. The plate was covered, incubated
at 37℃ for 2 hr, and then washed with 200  L/well phos-
phate-buffered saline Tween-20 (PBST) 3 times at intervals
of 3-4 min. With an addition of 3% bovine serum albumin
(BSA) 200  L/well, the plate was further incubated for 2 hr
at 37℃, and again washed 3 times with PBST. The plate was
incubated with primary antibody diluted at 1:200 with PBST
(100  L/well) at 37℃ for 2 hr, and washed 3 times with
PBST. Then, it was incubated with the secondary antibody
diluted at 1:1,500 with PBST (100  L/well) at 37℃ for 2
hr, and then washed 3 times with PBST. Finally with an addi-
tion of substrate peroxidase (POD) buffer (100  L/well), it
Fig. 1. Schematic drawing of irradiation. (a: diameter of radiation
tube; 0.6 cm, b: distance from the radiation source to the distal
cone; 0.5 cm, c: distance from source to the brain surface; 2 cm).
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was left at room temperature for 20 min for a reaction, and
then 50  L/well of 5N H2SO4 was added to stop the reaction.
By measuring the optical density with a precision microplate
reader with an ultraviolet length of 450 nm (Molecular Devices,
Sunnyvale, CA, U.S.A.), TNF- and TGF- 1 were quanti-
fied. The expression of TNF- and TGF- 1 with the lapse
of time after irradiation was measured in each experimental
group (irradiated right cerebral hemisphere and non-irradiat-
ed left hemisphere), and then the values were compared with
those of the sham operation group.
Immunohistochemical staining of TNF- and TGF- 1 
A paraffin section was heated in an incubator at 56-58℃
for 30 min, and then deparaffinized and dehydrated at room
temperature. To restrict the endogenous peroxydase activity,
the section was incubated for 10 min with methanol and
0.3% hydrogen peroxide, and then washed with phosphate-
buffered saline (PBS, pH 7.4) for 5 min 2-3 times. Then, it
was processed with a blocking solution (non-immune sheep
serum, DAKO kit 1:5, Carpinteria, CA, U.S.A.) at room tem-
perature for 20 min. The specimen was incubated with mono-
clonal anti-TNF- (Genetech, San Francisco, CA, U.S.A.)
and TGF 1 (V) (Rabbit Polyclonal IgG, Santa Cruz Biotech-
nology, Santa Cruz, CA, U.S.A.) diluted at 1:100 in PBS at
room temperature for 1 hr. Goat anti-mouse antibody, biotin-
labeled secondary antibody, and avidin-biotin complex were
administered for 1 hr each. After a 10-min incubation with
3,3-diaminobenzidine tetrahydrochloride (DAB) as a sub-
strate for a color reaction, the specimen was stained with
Mayer’ s hematoxylin, sealed up with a glycerol mounting
medium (DAKO-PATTS), and observed under an optic micro-
scope. As a positive control for the expression of cytokine, the
spleen and tonsillar tissues were used. With the help of a
pathologist, the cells with their nuclei stained dark brown
over the whole scope of the coronal section on the irradiated
cerebral cortex were checked using an optic microscope at a
200 magnification. The expression of TNF- and TGF- 1
with the lapse of time after irradiation was compared between
experimental groups.
Statistical processing
The expression of cytokine with the lapse of time after irra-
diation was statistically processed using the Sigmastat for
Windows version 1.0 (Jandel Corp., San Rafael, CA, U.S.A.).
One-way ANOVA was used to verify the measurements be-
tween experimental groups, and paired t-test was used to
verify the difference in measurements between right and left
cerebral hemispheres.
RESULTS
Histopathology with the lapse of time after irradiation
The loss of the irradiated cerebral cortex was 2.8±2.1%
(1 week), 7.9±1.5% (2 weeks), 35.3±6.4% (4 weeks),
53.1±2.3% (6 weeks), and 71.4±5.1% (8 weeks), which
showed a statistically significant increase with the lapse of
time (one-way ANOVA, p<0.05) (Fig. 2). A gradual loss of
the outermost molecular layer was also shown with the lapse
Fig. 2. Loss of cortical thickness according to the time in the irradiated hemisphere. *p<0.05 by one-way ANOVA. (A). Measurement of
loss of cortical thickness in the irradiated hemisphere (arrowheads), (b-a)/b×100 (%). (H-E stain, ×12.5) (B).
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of time after irradiation, and other characteristics including
fibrous gliosis, appearance of inflammation cells, prolifera-
tion of vascular endothelial cell, and necrosis increased. 
Quantitative analyses of cytokines with the lapse of
time after irradiation
The expressions of the TNF- and TGF- 1 in the irradi-
ated right cerebral hemispheres and non-irradiated left hemi-
spheres were quantified as follows. The expression of TNF-
in the irradiated right cerebral hemispheres was 111.4±8.0
pg/mL (1 week), 115.7±12.6 pg/mL (2 weeks), 125.6±10.1
pg/mL (4 weeks), 128.1±27.3 pg/mL (6 weeks), and 133.4±
11.0 pg/mL (8 weeks), which showed a statistically signifi-
cant increase as compared with 26.5±0.5 pg/mL in the sham
operation group (one- way ANOVA, p<0.05), but there was
no significant difference among the measurements through
1 week and 8 weeks (Fig. 3). The expression of TNF- in
the non-irradiated left cerebral hemispheres was 97.8±3.4
pg/mL (1 week), 98.4±3.5 pg/mL (2 weeks), 99.1±3.0
pg/mL (4 weeks), 99.2±5.4 pg/mL (6 weeks), and 99.6±
2.8 pg/mL (8 weeks), which showed statistically significant
increase when compared with 22±1.1 pg/mL in the sham
operation group, although the extent was smaller than in
the right cerebral hemispheres (one-way ANOVA, p<0.05).
The difference in the expression of TNF- between the right
and left cerebral hemispheres was 13.6±8.5 pg/mL (1 week),
17.3±11.5 pg/mL (2 weeks), 26.5±11.7 pg/mL (4 weeks),
and 28.9±29.5 pg/mL (6 weeks), which showed statistical-
ly significant differences (paired t-test, p<0.05).
The expression of TGF- 1 in the irradiated right cerebral
hemispheres was 117.5±16.3 pg/mL (1 week), 123.3±11.1
pg/mL (2 weeks), 127.1±12.6 pg/mL (4 weeks), 139.9±
32.4 pg/mL (6 weeks), and 189.3±14.6 pg/mL (8 weeks),
which showed a statistically significant increase with the lapse
of time when compared with 19.5±9.1 pg/mL in the sham
operation group (one-way ANOVA, p<0.05) and this increase
was more prominent at 8 weeks after irradiation (Fig. 4). The
expression of TGF- 1 in the non-irradiated left cerebral he-
mispheres was 95.3±17.1 pg/ mL (1 week), 94.9±12.6 pg/
mL (2 weeks), 99.4±15.4 pg/ mL (4 weeks), 99.1±7.6 pg/
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Fig. 3. Expressions of TNF- according to the time after irradiation.
*p<0.05 by one-way ANOVA, 
� p<0.05 by paired t-test.
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Fig. 4. Expression of TGF- 1 according to the time after irradiation.
*p<0.05 by one-way ANOVA, 
� p<0.05 by paired t-test.
Fig. 5. Immunohistochemical findings demonstrating the expres-
sion of TGF- 1 after irradiation. TGF- 1 is expressed predominant-
ly by infiltrating macrophages (arrowhead) and astrocytes (arrow)
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mL (6 weeks), and 101.5±6.5 pg/mL (8 weeks), which
showed a significant increase when compared with 15.5±
8.8 pg/mL in the sham operation group, although the extent
was smaller than in the right cerebral hemispheres (one-way
ANOVA, p<0.05). The difference in the expression of TGF- 1
between the right and left cerebral hemispheres was 22.2±
10.0 pg/mL (1 week), 28.4±17.9 pg/mL (2 weeks), 27.7±
13.2 pg/mL (4 weeks), and 40.8±29.2 pg/mL (6 weeks),
which showed statistically significant differences (paired t-
test, p<0.05).
Immunohistochemical analyses of the expression of
TNF- and TGF- 1
Immunohistochemical staining for TNF- showed severe
cross reactivities, so that the results could not be interpretat-
ed. Immunohistochemical staining for TGF- 1 clearly showed
the positive expression of TGF- 1 in necrosis-neighboring
areas and the origins of the expression were macrophages and
proliferating astrocytes (Fig. 5).
DISCUSSION
A number of studies on malignant brain tumor have been
made to date and revealed that a higher dose of irradiation
would be more effective in killing the remaining brain tumor
cells in most cases (14, 15). The development of neuroimag-
ing technology enabled the replacement of the standard exter-
nal beam radiation (teletherapy) with a relatively wide range
of irradiation with the interstitial brachytherapy or the focused
beam teletherapy using a gamma knife or linear accelerator
(3, 7, 16, 17). Recently, intraoprative radiation therapy (IORT)
is clinically used for a more effective radiation and many re-
searchers are employing this method. IORT enables the intra-
operative direct examination of tumors and delivery of a great
amount of radiation on the tumor site, which can maximize
the radiation effect and prevent the recurrence of tumors effec-
tively (14). It is believed, however, that even with a shield in
place during irradiation to protect normal tissues at a maxi-
mum efficacy, irradiation may cause a considerable damage
to normal cerebral tissues (18). It is well assumed that such
damage may be different from that with a relatively low radi-
ation so-called conventional radiotherapy, however, few studies
have been made on radiation injuries after a single high-dose
irradiation, such as radiation necrosis and apoptosis. Cerebral
injury due to irradiation has been widely known to vary from
a temporary malfunction to overall changes in quality, but the
precise physiopathological mechanisms have not been clarified
yet. There are hypotheses that a number of cytokines and im-
munoregulatory molecules expressed in the irradiated brain
cells may be involved in enhancing the vascular permeability
and causing cytotoxicity, astrocytosis, or glial proliferation
(19-23). According to Calvo et al. (24), the incidence of necro-
sis in the cerebral white matter of the rat after a high-dose
irradiation is closely related to the amount of radiation and the
lapse of time after irradiation. The higher dose of radiation
and the more lapse of time after irradiation were associated
with the more serious injury of cerebral tissues because of
necrosis due to the proliferation of vascular endothelial cells.
Our study also found that over an 8-week period (subacute
stage) after irradiation of 10 Gy on normal cerebral tissues of
the rats, the outermost molecular layer and the overall corti-
cal thickness of the irradiated site were gradually lost with the
lapse of time, accompanied with gradual increases in fibrous
gliosis, appearance of inflammation cells, proliferation of vas-
cular endothelial cell, and necrosis.
Various cytokines and growth factors play an important
role in controlling the growth and differentiation of normal
cerebral and cancer cells exposed to radiation (25), and focus
is now placed upon the roles of the cytokines in normal or
troubled cerebral tissues (8, 26-28). Recent studies have found
that the radiation accelerates the expression of mRNA of
TNF- (2, 10). Kureshi et al. reported that cerebral biopsy
after radiation treatment for patients with brain tumors re-
vealed a considerable increase of TNF- , interleukin-6 (IL-
6), and TGF- (3). Our study also found that TGF- 1 was
strongly expressed in macrophages and proliferating astro-
cytes around the site of necrosis. TNF- is a 17 kDa polypep-
tide, which is typical cytokine produced mainly by macro-
phages and monocytes (29, 30).
TNF- is an intermediator of the immune system protect-
ing the host from attacks of various infections and cancer cells,
and notably, induces death of cancer cells by causing apop-
tosis (9). It has also been known that TNF- induces the pro-
duction of various cytokines in human cells, e.g., interleukin-
1 (IL-1) in vascular endothelial cells and tumor cells, and IL-
6 in fibroblasts (31-34). Helseth et al. reported that TNF-
accelerated the cytotoxity of TGF- in human glioblastoma
cells (35). Chiang et al. reported the in vitro findings that a
low-dose irradiation caused the production of TNF- in micro-
glial cells and astrocytes (2). In addition, there has been a
report that the production of TNF- was increased in cultured
monocytes taken from patients who had underwent a radia-
tion treatment (36). Based on these study results, the expres-
sion of TNF- caused by radiation was assumed to play an
important role in relation to several complications after irra-
diation. Neta et al. reported that the injection of TNF- into
the rat before irradiation caused a radioprotective effect in
the hematopoietic system while the pretreatment of an anti-
body against TNF- decreased the survival of experimental
animals, demonstrating that TNF- served as the innate de-
fense mechanism against radiation by restricting oxidative
damage and inducing bcl-2 genes, and thereby decreasing
apoptosis (38, 39). Based on these findings, Kureshi et al.
asserted that TNF- might be involved in the physiological
radioresistance and recovery process (3). However, the exact
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dose radiation are not clearly established up to now.
TGF- produced mainly from astrocytes and macrophages
is a polypeptide with various biological actions in the human
body and composed of 5 subtypes (39-42). TGF- 1, a typi-
cal subtype, is 25 kDa homodimer protein made up of 112
amino acid polypeptides (39). TGF- has been reported to
work in two directions, i.e., to restrict or accelerate the growth
of cancer (43). It serves as a defensive molecule restricting the
proliferation of cancer cells at least during the initial devel-
opment (44, 45). There was a report that a high dose of irra-
diation increased the expression of TGF- in the rat liver (3).
Neta et al. asserted that TGF- should decrease the produc-
tion of TNF- in the hematopoietic system, thereby serving
as a radiosensitizer (37). Using cerebral biopsy specimen in
patients with brain tumor who had underwent a radiation
treatment, Kureshi et al. reported that TNF- and IL-6 were
expressed mainly by macrophages and TGF- by astrocytes
and macrophages (3). The present study also shows consis-
tent results, finding that TGF- 1 was expressed mainly by
macrophages and astrocytes after a single high-dose irradia-
tion.
In the present study, we found that the expressions of TNF-
and TGF- 1 in the irradiated right cerebral hemispheres
were significantly increased with the lapse of time during an
8-week post-radiation period (subacute stage) when compared
with those in the sham operation group. These results are
consistent with the report that the functions of TNF- and
TGF- 1 are not fixed but have a multidirectional nature de-
pending on given cells, tissues, and their conditions, through
a cascade and interaction with other cytokines. In this man-
ner, they relate to the proliferation of astrocytes, vascular
endothelial cells, and the destruction of blood-brain barriers
usually shown after irradiation and contribute to the radia-
tion injury including gliosis, vascular injury, and necrosis
(3). Further studies are needed to clarify the mechanisms for
the interactions among various cytokines, including TNF-
and TGF- 1, in irradiated cerebral tissues. Of note, our study
showed that the expressions of TNF- and TGF- 1 were also
significantly increased in the non-irradiated left cerebral hemi-
spheres, although such increase was smaller than that in the
irradiated hemispheres. Although the mechanism is unclear,
these results suggest the possibilities of inflammation caused
by burrhole procedure or migration of macrophages to the
opposite hemispheres from the irradiated hemisphere or in-
flow of cytokines through the tissue fluid.
In summary, we demonstrated that the radiation injuries
after a single high-dose irradiation that is used for various
malignant tumors in recent days consist of radiation necro-
sis and apoptosis, which were associated with the expression
of TNF- and TGF- 1. If we can clarify the roles of cytokines
in relation to radiation injury, we can develop methods of
restricting or accelerating the expression of the cytokines,
which will contribute to the prevention of complications
after radiation therapy.
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